In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 24th, 2004 | 23 | Yes |
Popular Name: 2-(4-ethoxyphenyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one 2-(4-ethoxyphenyl)-5,6,7,8-tetra…
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.47 | -1.53 | -10.36 | 1 | 4 | 0 | 54 | 326.421 | 3 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CDN1A-1-E | CDK-interacting Protein 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 8400 | 0.31 | Functional ≤ 10μM |
Z80120-1-O | DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other | Other | 4600 | 0.32 | Functional ≤ 10μM |
Z80166-1-O | HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other | Other | 5000 | 0.32 | Functional ≤ 10μM |
Z80211-1-O | LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other | Other | 2600 | 0.34 | Functional ≤ 10μM |
Z80928-1-O | HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other | Other | 8400 | 0.31 | Functional ≤ 10μM |
Z81331-1-O | SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other | Other | 5000 | 0.32 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CDN1A_HUMAN | P38936 | CDK-interacting Protein 1, Human | 8400 | 0.31 | Functional ≤ 10μM |
Z80120 | Z80120 | DLD-1 (Colon Adenocarcinoma Cells) | 4600 | 0.32 | Functional ≤ 10μM |
Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 8400 | 0.31 | Functional ≤ 10μM |
Z80166 | Z80166 | HT-29 (Colon Adenocarcinoma Cells) | 5000 | 0.32 | Functional ≤ 10μM |
Z80211 | Z80211 | LoVo (Colon Adenocarcinoma Cells) | 2600 | 0.34 | Functional ≤ 10μM |
Z81331 | Z81331 | SW-620 (Colon Adenocarcinoma Cells) | 5000 | 0.32 | Functional ≤ 10μM |
Description | Species |
---|---|
AKT phosphorylates targets in the cytosol | |
Constitutive PI3K/AKT Signaling in Cancer | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin D associated events in G1 | |
Cyclin E associated events during G1/S transition | |
DNA Damage/Telomere Stress Induced Senescence | |
Orc1 removal from chromatin | |
p53-Dependent G1 DNA Damage Response | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) | |
Transcriptional activation of cell cycle inhibitor p21 |